dc.contributor.author |
Boulle, Andrew
|
en_ZA |
dc.contributor.author |
Schomaker, Michael
|
en_ZA |
dc.contributor.author |
May, Margaret T
|
en_ZA |
dc.contributor.author |
Hogg, Robert S
|
en_ZA |
dc.contributor.author |
Shepherd, Bryan E
|
en_ZA |
dc.contributor.author |
Monge, Susana
|
en_ZA |
dc.contributor.author |
Keiser, Olivia
|
en_ZA |
dc.contributor.author |
Lampe, Fiona C
|
en_ZA |
dc.contributor.author |
Giddy, Janet
|
en_ZA |
dc.contributor.author |
Ndirangu, James
|
en_ZA |
dc.date.accessioned |
2015-11-16T04:09:32Z |
|
dc.date.available |
2015-11-16T04:09:32Z |
|
dc.date.issued |
2014 |
en_ZA |
dc.identifier.citation |
Boulle, A., Schomaker, M., May, M. T., Hogg, R. S., Shepherd, B. E., Monge, S., ... & Sterne, J. A. (2014). Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLoS medicine, 11(9), e1001718. doi:10.1371/journal.pmed.1001718 |
en_ZA |
dc.identifier.uri |
http://hdl.handle.net/11427/14992
|
|
dc.identifier.uri |
http://dx.doi.org/10.1371/journal.pmed.1001718
|
|
dc.description.abstract |
Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy. Please see later in the article for the Editors' Summary |
en_ZA |
dc.language.iso |
eng |
en_ZA |
dc.publisher |
Public Library of Science |
en_ZA |
dc.rights |
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
en_ZA |
dc.rights.uri |
http://creativecommons.org/licenses/by/4.0 |
en_ZA |
dc.source |
PLOS Medicince |
en_ZA |
dc.source.uri |
http://journals.plos.org/plosmedicine
|
en_ZA |
dc.subject.other |
Death rates |
en_ZA |
dc.subject.other |
North America |
en_ZA |
dc.subject.other |
Europe |
en_ZA |
dc.subject.other |
South Africa |
en_ZA |
dc.subject.other |
Antiretroviral therapy |
en_ZA |
dc.subject.other |
HIV |
en_ZA |
dc.subject.other |
AIDS |
en_ZA |
dc.subject.other |
Viral load |
en_ZA |
dc.title |
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies |
en_ZA |
dc.type |
Journal Article |
en_ZA |
dc.rights.holder |
© 2014 Boulle et al |
en_ZA |
uct.type.publication |
Research |
en_ZA |
uct.type.resource |
Article
|
en_ZA |
dc.publisher.institution |
University of Cape Town |
|
dc.publisher.faculty |
Faculty of Health Sciences |
en_ZA |
dc.publisher.department |
Institute of Infectious Disease and Molecular Medicine |
en_ZA |
uct.type.filetype |
Text |
|
uct.type.filetype |
Image |
|
dc.identifier.apacitation |
Boulle, A., Schomaker, M., May, M. T., Hogg, R. S., Shepherd, B. E., Monge, S., ... Ndirangu, J. (2014). Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. <i>PLOS Medicince</i>, http://hdl.handle.net/11427/14992 |
en_ZA |
dc.identifier.chicagocitation |
Boulle, Andrew, Michael Schomaker, Margaret T May, Robert S Hogg, Bryan E Shepherd, Susana Monge, Olivia Keiser, Fiona C Lampe, Janet Giddy, and James Ndirangu "Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies." <i>PLOS Medicince</i> (2014) http://hdl.handle.net/11427/14992 |
en_ZA |
dc.identifier.vancouvercitation |
Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, et al. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLOS Medicince. 2014; http://hdl.handle.net/11427/14992. |
en_ZA |
dc.identifier.ris |
TY - Journal Article
AU - Boulle, Andrew
AU - Schomaker, Michael
AU - May, Margaret T
AU - Hogg, Robert S
AU - Shepherd, Bryan E
AU - Monge, Susana
AU - Keiser, Olivia
AU - Lampe, Fiona C
AU - Giddy, Janet
AU - Ndirangu, James
AB - Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy. Please see later in the article for the Editors' Summary
DA - 2014
DB - OpenUCT
DO - 10.1371/journal.pmed.1001718
DP - University of Cape Town
J1 - PLOS Medicince
LK - https://open.uct.ac.za
PB - University of Cape Town
PY - 2014
T1 - Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies
TI - Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies
UR - http://hdl.handle.net/11427/14992
ER -
|
en_ZA |